Description of the Company’s authorization to purchase of its own shares adopted during the general shareholders’ meeting on june 23, 2009

During the General Shareholders’ Meeting which took place on June 23, 2009, the general meeting of Innate Pharma (the Company - Euronext Paris: FR0010331421 – IPH) has authorized the Executive Board to purchase its own shares through a share repurchase program.